Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Udo Oppermann

Showing results (121-130 of 209) with videos related to

Pageof 21
Sort By:
Chemistry & Biology|December 21, 2010
Structural and mechanistic studies on γ-butyrobetaine hydroxylaseIvanhoe K H Leung, Tobias J Krojer, Grazyna T Kochan, et al.
Journal of the American Chemical Society|May 19, 2011
A selective inhibitor and probe of the cellular functions of Jumonji C domain-containing histone demethylasesXuelai Luo, Yongxiang Liu, Stefan Kubicek, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 16, 2019
AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cellsNikolaos Nikolaou, Laura L Gathercole, Lucy Kirkwood, et al.
The Journal of Biological Chemistry|November 19, 2010
Molecular characterization of a novel geranylgeranyl pyrophosphate synthase from Plasmodium parasitesJennifer D Artz, Amy K Wernimont, James E Dunford, et al.
Epigenetics & Chromatin|July 3, 2021
AF10 (MLLT10) prevents somatic cell reprogramming through regulation of DOT1L-mediated H3K79 methylationDeniz Uğurlu-Çimen, Deniz Odluyurt, Kenan Sevinç, et al.
Nature Chemical Biology|April 10, 2019
Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogrammingAyyub Ebrahimi, Kenan Sevinç, Gülben Gürhan Sevinç, et al.
Molecular Oncology|November 30, 2025
ATF4-mediated stress response as a therapeutic vulnerability in chordomaLucia Cottone, James Dunford, Eleanor Calcutt, et al.
Scientific Reports|January 3, 2024
PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivoElizabeth J Brown, Leire Balaguer-Lluna, Adam P Cribbs, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 15, 2018
Selective Inhibitors of a Human Prolyl Hydroxylase (OGFOD1) Involved in Ribosomal DecodingCyrille C Thinnes, Christopher T Lohans, Martine I Abboud, et al.
Science Translational Medicine|October 30, 2015
Inflammation activation and resolution in human tendon diseaseStephanie G Dakin, Fernando O Martinez, Clarence Yapp, et al.
Pageof 21

Showing results (121-130 of 209) with videos related to

Sort By:
Pageof 21
Chemistry & Biology|December 21, 2010
Structural and mechanistic studies on γ-butyrobetaine hydroxylaseIvanhoe K H Leung, Tobias J Krojer, Grazyna T Kochan, et al.
Journal of the American Chemical Society|May 19, 2011
A selective inhibitor and probe of the cellular functions of Jumonji C domain-containing histone demethylasesXuelai Luo, Yongxiang Liu, Stefan Kubicek, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 16, 2019
AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cellsNikolaos Nikolaou, Laura L Gathercole, Lucy Kirkwood, et al.
The Journal of Biological Chemistry|November 19, 2010
Molecular characterization of a novel geranylgeranyl pyrophosphate synthase from Plasmodium parasitesJennifer D Artz, Amy K Wernimont, James E Dunford, et al.
Epigenetics & Chromatin|July 3, 2021
AF10 (MLLT10) prevents somatic cell reprogramming through regulation of DOT1L-mediated H3K79 methylationDeniz Uğurlu-Çimen, Deniz Odluyurt, Kenan Sevinç, et al.
Nature Chemical Biology|April 10, 2019
Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogrammingAyyub Ebrahimi, Kenan Sevinç, Gülben Gürhan Sevinç, et al.
Molecular Oncology|November 30, 2025
ATF4-mediated stress response as a therapeutic vulnerability in chordomaLucia Cottone, James Dunford, Eleanor Calcutt, et al.
Scientific Reports|January 3, 2024
PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivoElizabeth J Brown, Leire Balaguer-Lluna, Adam P Cribbs, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 15, 2018
Selective Inhibitors of a Human Prolyl Hydroxylase (OGFOD1) Involved in Ribosomal DecodingCyrille C Thinnes, Christopher T Lohans, Martine I Abboud, et al.
Science Translational Medicine|October 30, 2015
Inflammation activation and resolution in human tendon diseaseStephanie G Dakin, Fernando O Martinez, Clarence Yapp, et al.
Pageof 21